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Benign bile duct strictures are commonly caused by stones, 
bile duct injury, sclerosing cholangitis, chronic pancreatitis, 
and congenital abnormalities. Bile duct changes caused by 
portal hypertension represent another group of uncommon 
causes of benign stricture. 
The earliest evidence of portal biliopathy was described by 
Hunt in 1965.1 Portal cavernoma biliopathy (PCB) is a rare 
condition caused by cavernomatous transformation of an 
extra-hepatic portal vein thrombosis (EHPVT). It is rarely 
symptomatic; however, due to compression of the biliary 
tree, it can result in biliary obstruction, choledocholithiasis, 
jaundice, and cholangitis.
Endoscopic therapy for symptomatic PCB is a matter of 
discussion since this condition is rare.2
We present a rare case of symptomatic PCB with a com-
mon bile duct (CBD) stricture, refractory to conventional 
endoscopic therapy in a patient unfit for surgery. Owing to 
the risk of repeated plastic stent exchange, we chose a more 
definite endoscopic approach with temporary placement of 
fully-covered self-expandable metal stent (fcSEMS). In this 
paper, we also report our successful results following applica-
tion of fcSEMS.
An 82-year-old man presented to our hospital with fever, 
right-upper quadrant abdominal pain, and jaundice. He had 
undergone cholecystectomy at another hospital for acute 
cholecystitis in 2002, complicated with an EHPVT. In addi-
tion, he had a history of aortic stenosis, hypertension, and 
congestive heart failure.
His laboratory values were indicative of leukocytosis 
(16.700/uL) and elevated liver enzymes, with a total bilirubin 
of 8.9 mg/dL.
Abdominal ultrasound revealed dilated intrahepatic bile 
ducts (IHBD) and CBD, as well as an EHPVT.
The patient was diagnosed with acute cholangitis and 
treated with antibiotics. Endoscopic retrograde cholan-
gio-pancreatography (ERCP) showed asymmetric stenosis in 
the middle portion of the CBD (compatible with portal bili-
opathy type I2) and some small stones above it, with dilation 
of the proximal CBD and IHBD (Fig. 1A). After sphincterot-
omy and careful stone extraction with Dormia’s basket, a 10-
Fr plastic stent was placed. Balloon dilation was avoided due 
to hemobilia risk, which has been reported before.3,4
Abdominal computed tomography (CT) scan with con-
trast revealed a portal cavernoma compressing the middle 
segment of the CBD and causing the stricture seen during 
ERCP (Fig. 2).
The patient was not a candidate for portal decompression 
(transjugular portosystemic shunt was not feasible and he 
was unfit for surgery due to his advanced age and comorbid-
ities), so progressive biliary plastic stenting was performed 
every 3 months. However, after one year, there was no im-
provement in the CBD stenosis and the patient still had ele-
vated liver enzymes and IHBD dilation.
Following failure of progressive plastic stenting, tempo-
rary placement of a 80×10-mm fcSEMS (Wallflex®, Boston 
Scientific) was planned. The stent was deployed (Fig. 1B) and 
removed 6 months later (thereafter) without complications 
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and revealing improvement of the stricture (Fig. 1C).
Liver enzymes became normal, the patient remained as-
ymptomatic, and there was no need for additional endoscop-
ic therapy in the last 12 months.
Currently, data on the endoscopic treatment of portal bili-
opathy strictures are insufficient.5 As for endoscopic therapy, 
the risk of hemobilia has been studied as a major concern 
during endoscopic management of PCB. In particular, in-
tra-choledochal varices, masquerading as filling defects, may 
be the source of bleeding during calculi extraction. More-
over, manipulation of the bile duct also carries a significant 
risk of complications. Hemobilia has also been reported for 
other interventions6 such as exchange of plastic stents, pneu-
matic balloon dilatation of stricture, and balloon-occluding 
cholangiogram during endoscopic management of PCB.
Therefore, surgery is advised for symptomatic cases of 
PCB, whenever possible.
When surgery is not feasible or the patient is not fit for 
surgery (which was the case of our patient due to advanced 
age and comorbidities), plastic stenting is advised. However, 
it is also important to remember that repeated plastic stent-
ing carries a possible risk of complications and, in refractory 
strictures, infinite exchanging of stents should ideally be 
avoided.
There are no guidelines regarding the use of SEMS in 
symptomatic PCB mainly due to very limited experience.5 
Moreover, cases managed with a successful and uncompli-
cated temporary placement of fcSEMS have been rarely re-
ported.7,8 Apart from possible migration, as with other stric-
tures, excessive bleeding has been reported during removal 
of the metallic stent.9 However, in this report, a fcSEMS was 
the first treatment approach, which is not routinely recom-
Fig. 1. (A) Cholangiograms obtained during endoscopic retrograde cholangio-pancreatography (ERCP). Asymmetric stenosis in the middle portion of the common 
bile duct (CBD) (“pseudocholangiocarcinoma sign”) with small stones above it and dilation of the proximal biliary ducts. (B) Following failure of progressive plastic 
stenting, a 80×10-mm fully-covered self-expandable metal stents (fcSEMS) was placed. (C) Stent removal 6 months thereafter revealed improvement in the stenotic 
segment of the CBD.
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Fig. 2. Abdominal computed tomography (CT) scan with contrast showing typical changes of portal biliopathy including dilated peri-portal venous collaterals with a 
portal cavernoma, 3×2 cm (arrow), compressing the middle segment of the common bile duct (CBD) (with plastic stent in place). (A) Axial and (B) Coronal views.
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mended.
According to the results obtained in our case, we believe 
temporary placement of fcSEMS might be a good option 
when surgery is contraindicated, progressive plastic stenting 
fails, and no episodes of hemobilia have occurred during 
previous endotherapy. It is reasonable to think that if bleed-
ing has not occurred during plastic stent exchanges, the risk 
for it to occur during removal of a metal stent is smaller. 
However, more data are needed regarding this PCB treat-
ment approach. 
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